UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Objective measurement and clinical significance of TILs in non-small cell lung cancer

JNCI : Journal of the National Cancer Institute, 2015-03, Vol.107 (3), p.1

2015

Volltextzugriff (PDF)

Mechanisms of checkpoint inhibition‐induced adverse events

Clinical and experimental immunology, 2020-05, Vol.200 (2), p.141-154

2020

Volltextzugriff (PDF)

Sarcopenia and high NLR are associated with the development of hyperprogressive disease after second‐line pembrolizumab in patients with non‐small‐cell lung cancer

Clinical and experimental immunology, 2020-12, Vol.202 (3), p.353-362

2020

Volltextzugriff (PDF)

Single-cell transcriptomics reveals tumor-infiltrating B cell function after neoadjuvant pembrolizumab and chemotherapy in non-small cell lung cancer

Journal of leukocyte biology, 2024-09, Vol.116 (3), p.555-564

2024

Volltextzugriff (PDF)

Ginsenoside Rh2 reverses cyclophosphamide‐induced immune deficiency by regulating fatty acid metabolism

Journal of leukocyte biology, 2019-11, Vol.106 (5), p.1089-1100

2019

Volltextzugriff (PDF)

The effect and safety of immune checkpoint inhibitor rechallenge in non-small cell lung cancer

Japanese journal of clinical oncology, 2019-08, Vol.49 (8), p.762-765

2019

Volltextzugriff (PDF)

Serum inflammatory factors and circulating immunosuppressive cells are predictive markers for efficacy of radiofrequency ablation in non‐small‐cell lung cancer

Clinical and experimental immunology, 2015-06, Vol.180 (3), p.467-474

2015

Volltextzugriff (PDF)

Digitally quantified CD8+ cells: the best candidate marker for an immune cell score in non-small cell lung cancer?

Carcinogenesis (New York), 2020-12, Vol.41 (12), p.1671-1681

2020

Volltextzugriff (PDF)

Re: Two centres’ experience with lung cancer resection in patients with advanced non-small-cell lung cancer following treatment with immune checkpoint inhibitors: safety and clinical outcomes

European journal of cardio-thoracic surgery, 2021-12, Vol.60 (6), p.1306-1307

2021

Volltextzugriff (PDF)

Blood and lymphatic vessels contribute to the impact of the immune microenvironment on clinical outcome in non-small-cell lung cancer

European journal of cardio-thoracic surgery, 2018-06, Vol.53 (6), p.1205-1213

2018

Volltextzugriff (PDF)

Current status of immunotherapy

Japanese journal of clinical oncology, 2016-03, Vol.46 (3), p.191-203

2016

Volltextzugriff (PDF)

Genetic variants of immunoglobulin γ and κ chains influence humoral immunity to the cancer‐testis antigen XAGE‐1b (GAGED2a) in patients with non‐small cell lung cancer

Clinical and experimental immunology, 2014-04, Vol.176 (1), p.78-83

2014

Volltextzugriff (PDF)

Association between 18 F-FDG metabolic activity and programmed death ligand-1 (PD-L1) expression using 22C3 immunohistochemistry assays in non-small cell lung cancer (NSCLC) resection specimens

British journal of radiology, 2021-03, Vol.94 (1119), p.20200397

2021

Volltextzugriff (PDF)

Erythropoietin receptor expression in non-small cell lung carcinoma: a question of antibody specificity

Stem cells (Dayton, Ohio), 2007-03, Vol.25 (3), p.718-722

2007

Volltextzugriff (PDF)

Current clinical immunotherapy targets in advanced nonsmall cell lung cancer (NSCLC)

Journal of leukocyte biology, 2013-12, Vol.94 (6), p.1201-1206

2013

Volltextzugriff (PDF)

Granulocyte-macrophage colony-stimulating factor gene-modified autologous tumor vaccines in non-small-cell lung cancer

JNCI : Journal of the National Cancer Institute, 2004-02, Vol.96 (4), p.326-331

2004

Volltextzugriff (PDF)

Polymorphisms in immunoregulatory genes, smoky coal exposure and lung cancer risk in Xuan Wei, China

Carcinogenesis (New York), 2007-07, Vol.28 (7), p.1437-1441

2007

Volltextzugriff (PDF)

Increased numbers but functional defects of CD56+CD3+ cells in lung cancer

International immunology, 2012-07, Vol.24 (7), p.409-415

2012

Volltextzugriff (PDF)

Anti-α-enolase Autoantibodies Are Down-regulated in Advanced Cancer Patients

Japanese journal of clinical oncology, 2010-07, Vol.40 (7), p.663-669

2010

Volltextzugriff (PDF)

Lung Cancer Survival and Functional Polymorphisms in MBL2, an Innate-Immunity Gene

JNCI : Journal of the National Cancer Institute, 2007-09, Vol.99 (18), p.1401-1409

2007

Volltextzugriff (PDF)

Immune System's Toll-like Receptors Have Good Opportunity for Cancer Treatment

JNCI : Journal of the National Cancer Institute, 2006-05, Vol.98 (9), p.574-575

Schmidt, Charlie

2006

Volltextzugriff (PDF)

dendritic cell-based tumour vaccine for lung cancer: full-length XAGE-1b protein-pulsed dendritic cells induce specific cytotoxic T lymphocytes in vitro

Clinical and experimental immunology, 2008-09, Vol.153 (3), p.392-400

2008

Volltextzugriff (PDF)

Video-assisted thoracic surgery lobectomy for lung cancer is associated with less immunochemokine disturbances than thoracotomy

European journal of cardio-thoracic surgery, 2007-01, Vol.31 (1), p.83-87

2007

Volltextzugriff (PDF)

Potentiation of NK cell-mediated cytotoxicity in human lung adenocarcinoma: role of NKG2D-dependent pathway

International immunology, 2008-07, Vol.20 (7), p.801-810

2008

Volltextzugriff (PDF)

Alteration of the immunological synapse in lung cancer: a microenvironmental approach

Clinical and experimental immunology, 2008-10, Vol.154 (1), p.48-55

2008

Volltextzugriff (PDF)

1 – 25 von 60

Suche als RSS-Feed

Aktive Filter

KollektionOxford Journals

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(60)
Mit Volltextzugriff
(55)

Publikationsform

Artikel
(60)

Sprache

Englisch
(60)

Erscheinungsjahr

n.n

Thema

Humans
(58)
Life Sciences & Biomedicine
(57)
Science & Technology
(57)
Lung Neoplasms - Immunology
(38)
Carcinoma, Non-Small-Cell Lung - Immunology
(37)
Male
(28)
Female
(27)
Immunology
(26)
Middle Aged
(26)
Aged
(24)
Lung Cancer
(22)
Carcinoma, Non-Small-Cell Lung - Pathology
(21)
Lung Neoplasms - Pathology
(21)
Oncology
(19)
Biological And Medical Sciences
(17)
Medical Sciences
(17)
Adult
(15)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(14)
Lung Neoplasms - Drug Therapy
(14)
Aged, 80 And Over
(13)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Objective measurement and clinical significance of TILs in non-small cell lung cancer

Mechanisms of checkpoint inhibition‐induced adverse events

Sarcopenia and high NLR are associated with the development of hyperprogressive disease after second‐line pembrolizumab in patients with non‐small‐cell lung cancer

Single-cell transcriptomics reveals tumor-infiltrating B cell function after neoadjuvant pembrolizumab and chemotherapy in non-small cell lung cancer

Ginsenoside Rh2 reverses cyclophosphamide‐induced immune deficiency by regulating fatty acid metabolism

The effect and safety of immune checkpoint inhibitor rechallenge in non-small cell lung cancer

Serum inflammatory factors and circulating immunosuppressive cells are predictive markers for efficacy of radiofrequency ablation in non‐small‐cell lung cancer

Digitally quantified CD8+ cells: the best candidate marker for an immune cell score in non-small cell lung cancer?

Re: Two centres’ experience with lung cancer resection in patients with advanced non-small-cell lung cancer following treatment with immune checkpoint inhibitors: safety and clinical outcomes

Blood and lymphatic vessels contribute to the impact of the immune microenvironment on clinical outcome in non-small-cell lung cancer

Current status of immunotherapy

Genetic variants of immunoglobulin γ and κ chains influence humoral immunity to the cancer‐testis antigen XAGE‐1b (GAGED2a) in patients with non‐small cell lung cancer

Association between 18 F-FDG metabolic activity and programmed death ligand-1 (PD-L1) expression using 22C3 immunohistochemistry assays in non-small cell lung cancer (NSCLC) resection specimens

Erythropoietin receptor expression in non-small cell lung carcinoma: a question of antibody specificity

Current clinical immunotherapy targets in advanced nonsmall cell lung cancer (NSCLC)

Granulocyte-macrophage colony-stimulating factor gene-modified autologous tumor vaccines in non-small-cell lung cancer

Polymorphisms in immunoregulatory genes, smoky coal exposure and lung cancer risk in Xuan Wei, China

Increased numbers but functional defects of CD56+CD3+ cells in lung cancer

Anti-α-enolase Autoantibodies Are Down-regulated in Advanced Cancer Patients

Lung Cancer Survival and Functional Polymorphisms in MBL2, an Innate-Immunity Gene

Immune System's Toll-like Receptors Have Good Opportunity for Cancer Treatment

dendritic cell-based tumour vaccine for lung cancer: full-length XAGE-1b protein-pulsed dendritic cells induce specific cytotoxic T lymphocytes in vitro

Video-assisted thoracic surgery lobectomy for lung cancer is associated with less immunochemokine disturbances than thoracotomy

Potentiation of NK cell-mediated cytotoxicity in human lung adenocarcinoma: role of NKG2D-dependent pathway

Alteration of the immunological synapse in lung cancer: a microenvironmental approach

Aktive Filter

Suchergebnisse filtern